Edge Therapeutics reverse merges with PDS Biotechnology
- Large Molecule
- Nanotechnology, Chips, etc.
- Payment Includes Stock
- Reverse Acquisition
- Includes Contract
- Intra-Biotech Deal
- Full Acquisition
- Acquisition of Private Biotech
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.